Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    China AI chips ramp up as Nvidia H200 access unclear

    May 14, 2026

    Reform loses control of county council

    May 14, 2026

    Venezuela embarks on $150 billion restructuring of sovereign, oil debt

    May 14, 2026
    Facebook X (Twitter) Instagram
    Addison Markets
    • Home
    • USA
    • Europe
    • Business
    • Investing
    • Tech
    • Politics
    • Contact Us
    Addison Markets
    Home»Tech»Altman forced to confront claims at OpenAI trial that he’s a prolific liar
    Tech

    Altman forced to confront claims at OpenAI trial that he’s a prolific liar

    franperez66q@protonmail.comBy franperez66q@protonmail.comMay 14, 2026No Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email



    By contrast, Musk did want total control, Altman testified, and he walked when he didn’t get it. And although Altman agreed that Musk had said he would quickly give up that control, Altman didn’t trust that, he testified. He emphasized that when he was at Y Combinator, an incubator for startups, he “had seen a lot of control fights,” where “no one wanted to give up power when things were going well,” The Verge reported.

    Further, Altman testified that Musk had also indicated that he might never cede control. Altman claimed that when he asked Musk who might succeed him as OpenAI’s leader, Musk responded, “I haven’t thought about it a ton, but maybe control should pass to my children.”

    That was a “particularly hair-raising moment,” Altman testified.

    Musk tried to “kill” OpenAI, Altman says

    After Molo’s cross-examination ended, Savitt got Altman to further explain a text exchange that Musk’s lawyer highlighted, where Altman told Musk that he couldn’t have done OpenAI without him.

    Messages where Altman appears ingratiated to Musk seem to show that Musk did most of the heavy lifting when OpenAI was founded and therefore should be awarded damages up to $150 billion, which Musk intends to donate to OpenAI’s nonprofit.

    But Altman has claimed that Musk’s math makes no sense, essentially reducing the contributions of the other co-founders and OpenAI’s leading researchers to “zero.” On the stand, he testified that where other co-founders spent “every waking hour” building OpenAI, Musk only dropped in every other week or so and was mostly available via text and email when needed.

    Acknowledging the supposedly contradictory text to Musk, Altman testified that he has “many times” told Musk that he’s “grateful” for his help getting OpenAI off the ground. But ultimately, the best thing for OpenAI was for Musk to leave because his aggressive management style harmed morale and risked driving out talent. Notably, Musk nearly drove away a leading researcher after feeling unimpressed by an early presentation on a proto-ChatGPT model, OpenAI’s lawyers alleged.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    franperez66q@protonmail.com
    • Website

    Related Posts

    China AI chips ramp up as Nvidia H200 access unclear

    May 14, 2026

    Anthropic blames dystopian sci-fi for training AI models to act “evil”

    May 14, 2026

    Nvidia’s Jensen Huang on China trip: ‘Trump asked me to come’

    May 14, 2026

    Amazon devices chief says a new smartphone is “just not the goal”

    May 14, 2026

    Windows Update is getting better at saving your PC from buggy drivers

    May 14, 2026

    Neanderthals drilled cavities to treat a toothache 59,000 years ago

    May 14, 2026
    Leave A Reply Cancel Reply

    Top Reviews
    Editors Picks

    China AI chips ramp up as Nvidia H200 access unclear

    May 14, 2026

    Reform loses control of county council

    May 14, 2026

    Venezuela embarks on $150 billion restructuring of sovereign, oil debt

    May 14, 2026

    US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug

    May 14, 2026
    © 2026 All right reserved
    • Privacy Policy
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.